First-in-Class Alzheimer’s Drug Earns Federal Approval
For Alzheimer’s patients, the long wait is over.
Will Alzheimer’s Drugs Reach the Patients Who Need Them?
For the 6 million Americans living with Alzheimer’s disease, the wait for treatment options is almost over. Or is it?
